Katherine J. Olstad
ORCID: 0000-0003-3894-0981
· 1 paper in corpus
Anti-viral monoclonal antibody (mAb) treatments may provide immediate but short-term immunity from coronavirus disease 2019 (COVID-19) in high-risk populations, such as people with diabetes and the elderly; however, data on their efficacy i…